ConductScience.org, home

Paper28640596

Drug-Target Kinetics in Drug Discovery.

Tonge PJ. ACS Chem Neurosci, 2018. Cited by 216 papers, by iCite.

Cite this record

ConductScience Library. Drug-Target Kinetics in Drug Discovery. Papers, record 28640596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28640596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug-Target Kinetics in Drug Discovery.
PubMed
Journal
ACS Chem Neurosci
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
216
iCite
Relative citation ratio, by iCite
9.03
iCite
Revised in PubMed
2020-03-06
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tonge PJPeter Jhttps://orcid.org/0000-0003-1606-3471

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Central Nervous System NeoplasmsMajor topic
Drug DiscoveryMajor topic
Animals
Humans
Kinetics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM102864NIGMS NIH HHSUnited StatesR01GM102864PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127660682The Added Value of Assessing Ligand-Receptor Binding Kinetics in Drug Discovery.ACS Med Chem Lett2016https://conductscience.org/library/papers/27660682PubMed
224628038A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands.Br J Pharmacol2014https://conductscience.org/library/papers/24628038PubMed
315340390Biochemical mechanisms of drug action: what does it take for success?Nat Rev Drug Discov2004https://conductscience.org/library/papers/15340390PubMed
427096040Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR.ACS Med Chem Lett2016https://conductscience.org/library/papers/27096040PubMed
525630223Target engagement in lead generation.Bioorg Med Chem Lett2015https://conductscience.org/library/papers/25630223PubMed
617334377Structure-guided development of affinity probes for tyrosine kinases using chemical genetics.Nat Chem Biol2007https://conductscience.org/library/papers/17334377PubMed
716888652Drug-target residence time and its implications for lead optimization.Nat Rev Drug Discov2006https://conductscience.org/library/papers/16888652PubMed
828412474Kinetics for Drug Discovery: an industry-driven effort to target drug residence time.Drug Discov Today2017https://conductscience.org/library/papers/28412474PubMed
925399643Targeting protein kinases with selective and semipromiscuous covalent inhibitors.Methods Enzymol2014https://conductscience.org/library/papers/25399643PubMed
1027414067Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer.J Med Chem2016https://conductscience.org/library/papers/27414067PubMed
1127547299Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.Chem Sci2016https://conductscience.org/library/papers/27547299PubMed
1226165720On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action.Expert Opin Drug Discov2015https://conductscience.org/library/papers/26165720PubMed
1326006698NanoBRET--A Novel BRET Platform for the Analysis of Protein-Protein Interactions.ACS Chem Biol2015https://conductscience.org/library/papers/26006698PubMed
1426484747Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients.Expert Opin Drug Discov2016https://conductscience.org/library/papers/26484747PubMed
1523709115Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans.J Pharmacol Exp Ther2013https://conductscience.org/library/papers/23709115PubMed
1622823083The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety.Expert Opin Drug Discov2010https://conductscience.org/library/papers/22823083PubMed
1727094554Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.Sci Rep2016https://conductscience.org/library/papers/27094554PubMed
1827317944Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy.Pharmacol Res2016https://conductscience.org/library/papers/27317944PubMed
1927090615Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9.ACS Chem Biol2016https://conductscience.org/library/papers/27090615PubMed
2026158339Type II Inhibitors Targeting CDK2.ACS Chem Biol2015https://conductscience.org/library/papers/26158339PubMed

See all 77 referencesDownload CSV of references

Cited by132

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.

PMIDTitleJournalYearIn PapersSource
42941873Peptides and Peptide Analogues Targeting Acetylcholinesterase-Associated Mechanisms in Alzheimer's Disease and Dementias: Evidence Gaps, Design Strategies, and Translational Perspectives.Int J Mol Sci2026https://conductscience.org/library/papers/42941873PubMed
42783177Retention-Based, Dissociation-Sensitive Pre-Screening of Aptamers Using a Centrifugal Microspin Filter.Biosensors (Basel)2026https://conductscience.org/library/papers/42783177PubMed
42771273Ligand-induced reshaping of the conformational free energy landscape drives dynamic restriction in Trypanosoma brucei alternative oxidase.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42771273PubMed
42310671Thermodynamic variations at the HPV E1-E2 interface correlate with clinical risk groups: an in-silico analysis.Virol J2026https://conductscience.org/library/papers/42310671PubMed
42250658The post antibiotic effect of streptogramins on gram-positive bacteria primarily arises from the type a component.Microb Pathog2026https://conductscience.org/library/papers/42250658PubMed
42239232Protein-ligand binding kinetics are primarily controlled by the protein, not the ligand.bioRxiv2026https://conductscience.org/library/papers/42239232PubMed
42154562Rebinding drives cellular retention of small-molecule drugs with abundant targets.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42154562PubMed
41992795Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies.Brain Behav2026https://conductscience.org/library/papers/41992795PubMed
41824262Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.Ophthalmol Ther2026https://conductscience.org/library/papers/41824262PubMed
41698908A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.Nat Commun2026https://conductscience.org/library/papers/41698908PubMed
41687504Altered residence time as a cause of drug resistance.Curr Opin Struct Biol2026https://conductscience.org/library/papers/41687504PubMed
41604481Efflux pumps control intracellular drug-target kinetics by limiting rebinding in bacteria.Sci Adv2026https://conductscience.org/library/papers/41604481PubMed
41409161An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/41409161PubMed
41337752Selectivity of the Time-Dependent M. tuberculosis LeuRS Inhibitor Ganfeborole Is Driven by Target Vulnerability.ACS Chem Biol2025https://conductscience.org/library/papers/41337752PubMed
41332641A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects.bioRxiv2025https://conductscience.org/library/papers/41332641PubMed
41216209Demonstrating the Absence of Correlation Between Molecular Docking and in vitro Cytotoxicity in Anti-Breast Cancer Research: Root Causes and Practical Resolutions.Breast Cancer (Dove Med Press)2025https://conductscience.org/library/papers/41216209PubMed
41144873Conformational Quenching in an Engineered Lipocalin Protein Achieves High Affinity Binding to the Toxin Colchicine.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/41144873PubMed
40884937How residence time works in allosteric drugs.Curr Opin Struct Biol2025https://conductscience.org/library/papers/40884937PubMed
40726426Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects.J Am Chem Soc2025https://conductscience.org/library/papers/40726426PubMed
40634910Insights into the antiviral mechanisms of β-caryophyllene: inhibiting viral spread and its synergy with acyclovir.BMC Complement Med Ther2025https://conductscience.org/library/papers/40634910PubMed

See all 132 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28640596

GET https://conductscience.org/api/papers/v1/28640596/references?page=2